Cell Genesys (CEGE) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cell Genesys (CEGE)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: david james who wrote (884)	4/28/2000 2:56:00 PM
From: tuck	Read Replies (1) of 1298

david, Might be a while before CEGE gets U.S. TKTX revenue. They keep losing rounds in their patent dispute. I would speculate that at the very least they will have to pay some kind of license to AMGN, and that will offset their cheaper manufacturing costs. In another couple of months maybe there would be a ruling regarding an injunction on TKTX's right to manufacture Epogen at all. Apparently the trial is now set to move on to claims regarding manufacture. biz.yahoo.com Despite this, the positive press about gene therapy seems to outweigh this distant possibility. Which is fine with me. Analysis by someone with more legal/industry insight is welcome.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next